GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Veracyte Inc (FRA:12V) » Definitions » Construction In Progress

Veracyte (FRA:12V) Construction In Progress : €2.3 Mil (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Veracyte Construction In Progress?

Veracyte's quarterly construction in progress stayed the same from Jun. 2023 (€0.0 Mil) to Sep. 2023 (€0.0 Mil) but then increased from Sep. 2023 (€0.0 Mil) to Dec. 2023 (€2.3 Mil).

Veracyte's annual construction in progress declined from Dec. 2021 (€0.9 Mil) to Dec. 2022 (€0.6 Mil) but then increased from Dec. 2022 (€0.6 Mil) to Dec. 2023 (€2.3 Mil).


Veracyte Construction In Progress Historical Data

The historical data trend for Veracyte's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veracyte Construction In Progress Chart

Veracyte Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.91 0.63 0.88 0.55 2.26

Veracyte Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.55 - - - 2.26

Veracyte Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


Veracyte (FRA:12V) Business Description

Traded in Other Exchanges
Address
6000 Shoreline Court, Suite 300, South San Francisco, CA, USA, 94080
Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others. The company derives its revenues from the Sale of Afirma analysis products.

Veracyte (FRA:12V) Headlines

No Headlines